|
ZNF254 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.22819999726076E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.49479999676106E-08 |
| Normal-vs-Stage2 |
3.98219999975247E-07 |
| Normal-vs-Stage3 |
3.23840000371334E-08 |
| Normal-vs-Stage4 |
2.43499664875912E-11 |
| Stage1-vs-Stage2 |
5.569400E-01 |
| Stage1-vs-Stage3 |
3.739400E-01 |
| Stage1-vs-Stage4 |
4.178700E-04 |
| Stage2-vs-Stage3 |
9.446000E-01 |
| Stage2-vs-Stage4 |
5.292300E-02 |
| Stage3-vs-Stage4 |
2.420100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63719999779488E-08 |
| Normal-vs-AfricanAmerican |
2.941700E-03 |
| Normal-vs-Asian |
8.16199999809086E-08 |
| Caucasian-vs-AfricanAmerican |
2.844200E-01 |
| Caucasian-vs-Asian |
6.016800E-01 |
| AfricanAmerican-vs-Asian |
2.093600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.05290000051994E-07 |
| Normal-vs-Female |
9.39830002710806E-09 |
| Male-vs-Female |
4.723000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.67520000280564E-08 |
| Normal-vs-Age(41-60Yrs) |
1.43620004777745E-10 |
| Normal-vs-Age(61-80Yrs) |
8.82069994823098E-09 |
| Normal-vs-Age(81-100Yrs) |
1.713960E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.154400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.564600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.821400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.108800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.285600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.510800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.477500E-03 |
| Classical-VS-Follicular |
3.016600E-01 |
| Classical-VS-Other |
7.525200E-01 |
| Classical-VS-Normal |
3.08259999970417E-07 |
| Tall-VS-Follicular |
1.138160E-01 |
| Tall-VS-Other |
3.335800E-01 |
| Tall-VS-Normal |
1.36250000171145E-09 |
| Follicular-VS-Other |
9.722200E-01 |
| Follicular-VS-Normal |
4.28590000156603E-08 |
| Other-VS-Normal |
1.997670E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.39379618957491E-11 |
| Normal-vs-N1 |
1.18430000251024E-08 |
| N0-vs-N1 |
3.998000E-01 |
|
|
